This topic contains a solution. Click here to go to the answer

Author Question: A care conference is being held with the family of an older patient in the late stages of ... (Read 19 times)

rachel9

  • Sr. Member
  • ****
  • Posts: 495
A care conference is being held with the family of an older patient in the late stages of Alzheimer's disease. The family wants to know if a feeding tube should be placed. How should this question be answered?
 
  1. Tube feeding will aid the patient to gain weight.
  2. Tube feeding is associated with a reduced risk of aspiration.
  3. Tube feeding reduces the discomfort associated with dehydration.
  4. The absence of tube feeding promotes dehydration which reduces pain sensitivity.

Question 2

Which of the following assessment findings is most suggestive of deep-venous thrombosis?
 
  A) bilateral calf tenderness after walking up a flight of stairs
  B) swelling in one leg with pitting edema
  C) shortness of breath after activity
  D) two plus palpable pedal pulses



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lcapri7

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

4
Rationale: Tube feeding does not promote weight gain.

Answer to Question 2

B




rachel9

  • Member
  • Posts: 495
Reply 2 on: Jul 11, 2018
Thanks for the timely response, appreciate it


diana chang

  • Member
  • Posts: 288
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

For a complete list of videos, visit our video library